July 30, 2007
About time to get rid of B&L management!
Analysis: Current management, including the CEO who has admitted to lying on his resume, has not helped B&L rebound from its current difficulties in either the contact lens solution industry, nor the contact lens industry.
The contact lens solution plant that was recently re certified by the FDA could have been done a year ago when the FDA first stated problems occurred there. It took an additional 6 months, and a second recall to get it correct.
The contact lenses are the same design as previous HEMA lenses, in a silicone hydrogel material that has been around for years. Why wasn't the design switch years ago before Vistakon and Ciba?
Management has been responding to market challenges instead of creating them for other companies.
B&L has been a name in the optics industry for over 60 years. It has been decimated by poor management in the B & L sunglass division sold to Luxottica. B&L was the first company to come with a marketable soft contact lens, now it is a laggard. B&L had the best in soft lens solutions, and RGP solutions. Now it hasn't had anything new for years in either field.
Lets breath some new life into a stoodgy, poorly run company. Lets get a company that can make new markets instead of try to keep old ones.
Is there some reason that Mr. Zarella doesn't want an AMO takeover? Does it have to do with stock options, or golden parachutes?
Report a Concern
More GLG News in
Healthcare
ADAGIO Trial Results Show Teva's AZILECT(R) 1 Mg Tablets Slow Progression Of Parkinson's Disease
www.medicalnewstoday.com
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
www.therapeuticsdaily.com
Expanding Circle of Inhibition: Small-Molecule Inhibitors of Bcl-2 as Anticancer Cell and Antiangiogenic Agents
jco.ascopubs.org
ACE Inhibitor May Ease Cardiac Risks in Marfan's Syndrome
www.medpagetoday.com
Healthways' Guidance Not So Healthy
www.forbes.com
Azilect
September 2, 2008
Byetta Saves Lives
September 2, 2008
The Devil Is in the Details
September 1, 2008
Dangers of Methadone Usage
August 28, 2008
Healthways A Market Downturn and Results
August 26, 2008

